Metro International Biotech Announces Initial Dosing in the First Cohort of a Phase 1a Clinical Trial of its Novel NAD Booster MIB-725 - Business Wire

Metro International Biotech Announces Initial Dosing in the First Cohort of a Phase 1a Clinical Trial of its Novel NAD Booster MIB-725  Busi ...

Metro,International,Biotech,Announces,Initial,Dosing,in,the,First,Cohort